Therefore, in view of its key function in inhibiting the proliferation of human hepatoma cells, activation of MKK7 by Alpinetin offers a significant strategy for molecular therapy against hepatoma. The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.